Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer

Nature Reviews Urology · Published 2026-07-09 · DOI 10.1038/s41585-026-01172-5

Authors (15)

Sean A. Fletcher, Nicholas A. Pickersgill, Juan C. Osorio, Deaglan J. McHugh, Himanshu Nagar, Thomas Kole, James Janopaul-Naylor, Kristine Lacuna, James A. Eastham, Karim A. Touijer, Jonathan S. Fainberg, Howard I. Scher, Behfar Ehdaie, Matthew C. Dallos, Christopher D. Gaffney

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Fletcher, S., Pickersgill, N., Osorio, J., et al. (2026). Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer. Nature Reviews Urology. https://doi.org/10.1038/s41585-026-01172-5

Related articles

• Urolithiasis in patients with cancer · Nature Reviews Urology · 2026 · Same journal
• Bladder cancer research is blossoming in Birmingham · Nature Reviews Urology · 2026 · Same journal
• Animal models of spinal cord injury in neuro-urological research · Nature Reviews Urology · 2026 · Same journal
• Transitional urology: a comprehensive review of the transitional care process · Nature Reviews Urology · 2026 · Same journal
• Why counting women is not enough: from inclusion to equity in oncology trials · Nature Reviews Urology · 2026 · Same journal
• Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence · Nature Reviews Urology · 2026 · Same journal
• Leveraging generative AI to enhance doctor–patient communication · Nature Reviews Urology · 2026 · Same journal
• Implantable pelvic neurostimulators to restore erectile function: from concept to practice · Nature Reviews Urology · 2026 · Same journal
• The clinical utility of prostate MRI before biopsy · Nature Reviews Urology · 2026 · Same journal
• Circulating tumour cells as a window into lethality in prostate cancer · Nature Reviews Urology · 2026 · Same journal